ALNY

ALNYLAM PHARMACEUTICALS INC

ALNY·02043Q107·US·Common Stock·Healthcare - Biotechnology-13D/G

ALNY institutional ownership changes in Q2 2026: 153 institutions opened or added positions, 146 trimmed or exited. ALNY (ALNYLAM PHARMACEUTICALS INC) is held by 295 institutional investors as of Q2 2026. Top institutional shareholders: FMR LLC ($4.5B), Capital World Investors ($3.4B), BlackRock, Inc. ($3.3B). Net institutional sentiment: Mixed.

295
Holders
(21 Elite)
$36.9B
Total Value
51% (299)
Consensus
153 buying - 146 selling
13F: Insider & Congress: Updated regularly
ALNY

Smart Money Verdict

View all
Loading verdict
Held by 295 funds
21 elite

Who's Trading

Source dates: Price Oct 22, 2026 · Insiders Oct 6, 2026 · Activists May 14, 2026 · Congress Sep 9, 2026

InsiderSBSUPRAN BRYANSell $399KOct 2, 2026
InsiderGYGreenstreet YvonneVest 107 shSep 19, 2026
CongressCBCory A. BookerSale $1,001 - $15,000Aug 11, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
15M(+3.0%)$4.5B0.2%+23.62%
39
Increased
11.1M(+3.2%)$3.4B0.4%+16.34%
39
Increased
10.9M(+4.4%)$3.3B0.0%-18.16%
33
Increased
9.8M(+3.0%)$2.9B0.4%-11.86%
39
Increased
6.5M(+0.7%)$2B0.1%-29.89%
32
Increased
6M(+1.4%)$1.8B0.0%-29.85%
32
Decreased
3.8M(-7.9%)$1.1B0.1%-36.91%
0
Increased
3.6M(+7.0%)$1.1B0.0%+58.53%
34
Decreased
2.6M(-0.9%)$791.3M0.0%+37.38%
0
Decreased
2.7M(-57.7%)$785.3M0.0%-36.16%
0
Decreased
2.4M(-2.2%)$734.5M0.7%+127.32%
0
Increased
2.1M(+9.0%)$635.3M0.1%+48.59%
41
Increased
2M(+48.9%)$598.3M2.1%-17.58%
74
Increased
2M(+1.4%)$588.6M0.3%+132.98%
38
Decreased
1.9M(-5.8%)$564.7M0.4%-31.48%
0
Increased
1.9M(+2.9%)$558.1M0.2%+11.29%
39
Decreased
1.3M(-7.1%)$379.1M0.3%-30.69%
0
Decreased
1.1M(-19.8%)$345.9M0.0%+83.15%
0
Increased
1.1M(+4.3%)$332.4M0.2%-32.72%
39
Increased
1M(+2.9%)$310.7M0.0%-20.91%
32

Showing 1-20 of 304

1 / 16
ALNYALNYALNYLAM PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used